Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521 (Q41875348)
scientific article published on September 1, 1982
Language:
(P31) (Q13442814)
(P304) 347-355
(P407) (Q1860)
(P433) 3
(P478) 14
(P577) Wednesday, September 1, 1982
(P921) (Q422185)
(Q128406)
(Q725307)
(P953) https://europepmc.org/articles/PMC1427629
https://europepmc.org/articles/PMC1427629?pdf=render
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1982.tb01990.x
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1982.tb01990.x/fullpdf
(P1433) (Q176044)
(P1476) "Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521" (language: en)
(P2093) J. A. Millar
F. H. Derkx
K. McLean
J. L. Reid
(P2860) (Q41614815)
(Q42098372)
(Q34251984)
(Q33480770)
(Q48477421)
(Q54564559)
(Q41277535)
(Q40237372)
(Q40233477)
(Q40188829)
(Q39961753)
(Q39247233)
(Q59058380)
(Q72221005)
(Q66973982)
(Q71263039)
(Q72144499)
(Q72883821)
(Q72884678)
(Q72886500)
(Q72898071)
(Q70159491)
(Q70159522)
(Q70166632)
(Q70166657)
(Q72646762)
(Q78578227)
(Q68669025)
other details
description scientific article published on September 1, 1982

External Links